Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05942040 · ClinicalTrials.gov registry record · NA

Translating Data Science to Palliative Care

A NA study of Alzheimer's Disease and Related Dementias, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
301
Enrollment target
1
Study location

NCT05942040 is a NA study of Alzheimer's Disease and Related Dementias that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 301 participants, below the 1,579-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05942040, a NA study of Alzheimer's Disease and Related Dementias, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
301 participants
Enrollment target
1
Study location

Study Summary

This research study is intended to 1) better understand seriously ill adults' and their family care partners' (FCP), particularly for persons living with dementia (PLwD), barriers to accepting community-based palliative care (CBPC); 2) develop an intervention to address barriers; and 3) pilot test whether the intervention has an impact on CBPC uptake. The intervention will consist of 1) a set of informational material describing the benefits of CBPC for the CBPC team to use when presenting CBPC to members of a Medicare Advantage plan and their FCP; and 2) processes for tailoring information delivery so that eligible members and their FCP receive information about CBPC that reflects their individualized risk as identified by the Medicare Advantage program's validated 12-month mortality risk algorithm. The clinical trial portion of the study refers to the pilot test (Aim 3 as described below).

Interventions

  • OTHER Tailored Palliative Care Information

Study Locations (1)

New York

  • VNS Health - New York

Trial Details

FieldValue
Enrollment Target 301 participants
Start Date 2024-02-15
Est. Completion 2024-09-30
Phase NA

What the Registry Record Tells You About NCT05942040

The ClinicalTrials.gov registry entry for NCT05942040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,579-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (81% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer's Disease and Related Dementias appearing as the primary indexed condition, and to 1 intervention - of which Tailored Palliative Care Information is the first listed.

NCT05942040 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05942040 about?

NCT05942040 is a clinical study titled "Translating Data Science to Palliative Care". This research study is intended to 1) better understand seriously ill adults' and their family care partners' (FCP), particularly for persons living with dementia (PLwD), barriers to accepting community-based palliative care (CBPC); 2) develop an intervention to address barriers; and 3) pilot test w...

What is the current status of trial NCT05942040?

This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2024-02-15. Estimated completion is 2024-09-30.

What conditions does trial NCT05942040 study?

This clinical trial studies the following conditions: Alzheimer's Disease and Related Dementias.

What interventions are being tested in trial NCT05942040?

The interventions under investigation include: Tailored Palliative Care Information (OTHER).

Who is sponsoring clinical trial NCT05942040?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05942040 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer's Disease and Related Dementias

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.